OTC · Healthcare
Leef Brands Inc. (LEEEF)
As-reported financials and recent SEC filings for Leef Brands Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$34.8M
Net income
$-17.6M
Net margin
-50.7%
Diluted EPS
$-0.10
ROE
213.2%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2025 |
|---|---|---|
| Revenue | $34.8M | $28.5M |
| Gross profit | $10.5M | $7.7M |
| Operating income | $-7.6M | $-8.0M |
| Net income | $-17.6M | $-24.6M |
| Diluted EPS | $-0.10 | $-0.17 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-16
View on EDGAR →8-K2026-06-02
View on EDGAR →SCHEDULE 13G2026-05-22
View on EDGAR →42026-05-21
View on EDGAR →42026-05-21
View on EDGAR →10-Q2026-05-06
View on EDGAR →8-K2026-05-05
View on EDGAR →32026-04-24
View on EDGAR →Largest Healthcare peers
Go deeper on LEEEF
Search Leef Brands Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.